SERUM GLUTAMIC OXALACETIC TRANSAMINASE (SGO-T) IN CONGESTIVE HEART FAILURE: CLINICAL STUDY AND REVIEW OF THE LITERATURE
Authors: R G FRAGGE, F B KOPEL, A IGLAUER
Journal: Annals of Internal Medicine (1960)

Article1 May 1960SERUM GLUTAMIC OXALACETIC TRANSAMINASE (SGO-T) IN CONGESTIVE HEART FAILURE: CLINICAL STUDY AND REVIEW OF THE LITERATURERONALD G. FRAGGE, M.D., FREDRIC B. KOPEL, M.D., ARNOLD IGLAUER, M.D., F.A.C.P.RONALD G. FRAGGE, M.D.Search for more papers by this author, FREDRIC B. KOPEL, M.D.Search for more papers by this author, ARNOLD IGLAUER, M.D., F.A.C.P.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-52-5-1042 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptINTRODUCTIONConsiderable confusion has arisen in the interpretation of serum glutamic oxalacetic transaminase (SGO-T) levels as the number of clinical conditions to which this determination has been applied has increased. This refers in particular to congestive heart failure. Numerous series have been reported in which the levels of SGO-T have varied widely. Some observers have reported that acute congestive heart failure with liver engorgement may be associated with significant SGO-T elevation. Another author has stated that right heart failure does not ordinarily affect significantly the level of SGO-T activity.PROCEDURERecords of patients with congestive heart failure were surveyed from...Bibliography1. KarmenWróblewskiLaDue AFJS: Transaminase activity in human blood, J. Clin. Investigation 34: 126-133 (Jan.) 1955. CrossrefMedlineGoogle Scholar2. Sherlock S(a) : Diseases of the liver, edited by L. Schiff, 1956, J. B. Lippincott Co., Philadelphia, pp. 529-533. (b) Popper, H., and Schaffner, E.: Liver: structure and function, 1957, The Blakiston Co., pp. 473-478. Google Scholar3. MolanderWróblewskiLaDue DWFJS(a) : Serum glutamic oxalacetic transaminase as an index of hepatocellular integrity, J. Lab. and Clin. Med. 46: 831-839 (Dec.) 1955. (b) Wróblewski, F., Jervis, G., and LaDue, J. S.: The diagnostic, prognostic and epidemiologic significance of serum glutamic oxalacetic transaminase (SGO-T) alteration in acute hepatitis, Ann. Int. Med. 45: 782-800 (Nov.) 1956. MedlineGoogle Scholar4. ShieldsShannon LARE(a) : Acute hepatic congestion as a factor in elevated serum glutamic oxalacetic transaminase titers above 400 units, Am. J. M. Sc. 236: 438-446 (Oct.) 1958. (b) Dewar, H. A., Rowell, M. B., and Smith, A. J.: Serum glutamic oxalacetic transaminase in acute myocardial infarction, Brit. M. J. 2: 1121-1125 (Nov. 8) 1958. (c) Hanson, H., and Biorck, G.: Glutamic oxalacetic transaminase in the diagnosis of myocardial infarction, Acta med. scandinav. 157: 493-502 (June) 1957. CrossrefMedlineGoogle Scholar5. LiebermanLaskyDulkinLobstein JIISIOE: Serum glutamic oxalacetic transaminase activity in conditions associated with myocardial infarction, Ann. Int. Med. 46: 497-505 (Mar.) 1957. LinkGoogle Scholar6. ChinskySchmagranoffSherry MGLS(a) : Serum transaminase activity: observations in a large group of patients, J. Lab. and Clin. Med. 47: 108-118 (Jan.) 1956. (b) Chinsky, M., Wolff, R. J., and Sherry, S.: Serum transaminase activity. A comparison of pyruvic and oxalacetic transaminase, Am. J. M. Sc. 233: 400-408 (Apr.) 1957. (c) Denney, J. L., McAuley, C. B., Martin, H. E., Ware, A. G., and Segalove, M.: Evaluation of the serum glutamic oxalacetic aminopherase (transaminase) test, J. A. M. A. 161: 614-616 (June 16) 1956. (d) Dutoit, C. H., quoted by Conrad, F. B.: Transaminase, New England J. Med. 256: 602-607, 1957. (e) Kessler, G., and Phelps, A.: Serum glutamic oxaloacetic transaminase, J. Albert Einstein M. Center 4: 91-94 (June) 1956. (f) Ratner, J. T., and Sacke, H. J.: Transaminase in coronary artery disease, Canad. M. A. J. 76: 720-725 (May) 1957. MedlineGoogle Scholar7. Friedberg CK: Diseases of the heart, 2nd Ed., 1956, W. B. Saunders Co., Philadelphia, p. 511. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Cincinnati, Ohio*Received for publication October 8, 1959.From the Department of Internal Medicine, the Jewish Hospital Association, Cincinnati.†Present address: Brooklyn Jewish Hospital, Brooklyn, N. Y.Requests for reprints should be addressed to Ronald G. Fragge, M.D., Bellevue Hospital, Twenty-sixth Street and First Avenue, New York, N. Y. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byCardiac HepatopathyHypoxic hepatitisExtreme Elevation of Transaminase Levels in Acute Heart Disease-a Problem in Differential Diagnosis?LATE RISE IN SGPT AFTER ACUTE MYOCARDIAL INFARCTIONSerumenzyme nach ElektroregularisationTHE VALUE OF SERUM CREATINE PHOSPHOKINASE ESTIMATIONS IN THE DIAGNOSIS OF MYOCARDIAL INFARCTIONMyokinasebestimmungen in der Diagnostik des HerzinfarktsSerum α-hydroxybutyric dehydrogenase (HBD) in myocardial infarctionCardiac Failure Simulating Viral Hepatitis Three Cases with Serum Transaminase Levels above 1,000ROBERT G. LOGAN, M.D., FRANK M. MOWRY, M.D., RICHARD D. JUDGE, M.D.Alterations in indices of liver function in congestive heart failure with particular reference to serum enzymes 1 May 1960Volume 52, Issue 5Page: 1042-1050KeywordsAminotransferasesClinical chemistryEdemaElectrocardiographyEmphysemaHeart failureHospital medicineLongitudinal studiesResearch laboratoriesTechnicians ePublished: 1 December 2008 Issue Published: 1 May 1960 PDF downloadLoading ...